Cargando…

Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling

SIMPLE SUMMARY: Physiological changes to the body can affect the brain. For example, inflammation that originates in the body can be sensed by the brain. In this study, we used an agent called resiquimod (R848) to stimulate inflammation in the periphery and measured structural and metabolic brain re...

Descripción completa

Detalles Bibliográficos
Autores principales: Zahr, Natalie May, Zhao, Qingyu, Goodcase, Ryan, Pfefferbaum, Adolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869423/
https://www.ncbi.nlm.nih.gov/pubmed/35205140
http://dx.doi.org/10.3390/biology11020274
_version_ 1784656494299447296
author Zahr, Natalie May
Zhao, Qingyu
Goodcase, Ryan
Pfefferbaum, Adolf
author_facet Zahr, Natalie May
Zhao, Qingyu
Goodcase, Ryan
Pfefferbaum, Adolf
author_sort Zahr, Natalie May
collection PubMed
description SIMPLE SUMMARY: Physiological changes to the body can affect the brain. For example, inflammation that originates in the body can be sensed by the brain. In this study, we used an agent called resiquimod (R848) to stimulate inflammation in the periphery and measured structural and metabolic brain responses in anesthetized mice using in vivo magnetic resonance imaging. Relative to baseline prior to drug administration, a high dose of R848 caused sickness behaviors and volume expansion in several cortical regions at 3 h that were no longer evident at 24 h. Transient volume expansion in response to peripheral immune stimulation is consistent with brain swelling. ABSTRACT: Peripheral administration of the E. coli endotoxin lipopolysaccharide (LPS) to rats promotes secretion of pro-inflammatory cytokines and in previous studies was associated with transient enlargement of cortical volumes. Here, resiquimod (R848) was administered to mice to stimulate peripheral immune activation, and the effects on brain volumes and neurometabolites determined. After baseline scans, 24 male, wild-type C57BL mice were triaged into three groups including R848 at low (50 μg) and high (100 μg) doses and saline controls. Animals were scanned again at 3 h and 24 h following treatment. Sickness indices of elevated temperature and body weight loss were observed in all R848 animals. Animals that received 50 μg R848 exhibited decreases in hippocampal N-acetylaspartate and phosphocreatine at the 3 h time point that returned to baseline levels at 24 h. Animals that received the 100 μg R848 dose demonstrated transient, localized, volume expansion (~5%) detectable at 3 h in motor, somatosensory, and olfactory cortices; and pons. A metabolic response evident at the lower dose and a volumetric change at the higher dose suggests a temporal evolution of the effect wherein the neurochemical change is demonstrable earlier than neurostructural change. Transient volume expansion in response to peripheral immune stimulation corresponds with previous results and is consistent with brain swelling that may reflect CNS edema.
format Online
Article
Text
id pubmed-8869423
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-88694232022-02-25 Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling Zahr, Natalie May Zhao, Qingyu Goodcase, Ryan Pfefferbaum, Adolf Biology (Basel) Article SIMPLE SUMMARY: Physiological changes to the body can affect the brain. For example, inflammation that originates in the body can be sensed by the brain. In this study, we used an agent called resiquimod (R848) to stimulate inflammation in the periphery and measured structural and metabolic brain responses in anesthetized mice using in vivo magnetic resonance imaging. Relative to baseline prior to drug administration, a high dose of R848 caused sickness behaviors and volume expansion in several cortical regions at 3 h that were no longer evident at 24 h. Transient volume expansion in response to peripheral immune stimulation is consistent with brain swelling. ABSTRACT: Peripheral administration of the E. coli endotoxin lipopolysaccharide (LPS) to rats promotes secretion of pro-inflammatory cytokines and in previous studies was associated with transient enlargement of cortical volumes. Here, resiquimod (R848) was administered to mice to stimulate peripheral immune activation, and the effects on brain volumes and neurometabolites determined. After baseline scans, 24 male, wild-type C57BL mice were triaged into three groups including R848 at low (50 μg) and high (100 μg) doses and saline controls. Animals were scanned again at 3 h and 24 h following treatment. Sickness indices of elevated temperature and body weight loss were observed in all R848 animals. Animals that received 50 μg R848 exhibited decreases in hippocampal N-acetylaspartate and phosphocreatine at the 3 h time point that returned to baseline levels at 24 h. Animals that received the 100 μg R848 dose demonstrated transient, localized, volume expansion (~5%) detectable at 3 h in motor, somatosensory, and olfactory cortices; and pons. A metabolic response evident at the lower dose and a volumetric change at the higher dose suggests a temporal evolution of the effect wherein the neurochemical change is demonstrable earlier than neurostructural change. Transient volume expansion in response to peripheral immune stimulation corresponds with previous results and is consistent with brain swelling that may reflect CNS edema. MDPI 2022-02-10 /pmc/articles/PMC8869423/ /pubmed/35205140 http://dx.doi.org/10.3390/biology11020274 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Zahr, Natalie May
Zhao, Qingyu
Goodcase, Ryan
Pfefferbaum, Adolf
Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title_full Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title_fullStr Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title_full_unstemmed Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title_short Systemic Administration of the TLR7/8 Agonist Resiquimod (R848) to Mice Is Associated with Transient, In Vivo-Detectable Brain Swelling
title_sort systemic administration of the tlr7/8 agonist resiquimod (r848) to mice is associated with transient, in vivo-detectable brain swelling
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869423/
https://www.ncbi.nlm.nih.gov/pubmed/35205140
http://dx.doi.org/10.3390/biology11020274
work_keys_str_mv AT zahrnataliemay systemicadministrationofthetlr78agonistresiquimodr848tomiceisassociatedwithtransientinvivodetectablebrainswelling
AT zhaoqingyu systemicadministrationofthetlr78agonistresiquimodr848tomiceisassociatedwithtransientinvivodetectablebrainswelling
AT goodcaseryan systemicadministrationofthetlr78agonistresiquimodr848tomiceisassociatedwithtransientinvivodetectablebrainswelling
AT pfefferbaumadolf systemicadministrationofthetlr78agonistresiquimodr848tomiceisassociatedwithtransientinvivodetectablebrainswelling